Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Resuscitation|August 26, 2011
Circulating cell-free DNA levels correlate with postresuscitation survival rates in out-of-hospital cardiac arrest patientsChien-Hua Huang, Min-Shan Tsai, Chiung-Yuan Hsu, et al.
Oncotarget|August 28, 2015
Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathwaysYi-Hua Lai, Min-Hsuan Chen, Sih-Yin Lin, et al.
Injury|December 4, 2014
Hypothermia treatment preserves mitochondrial integrity and viability of cardiomyocytes after ischaemic reperfusion injuryChien-Hua Huang, Chih-Yen Chiang, Ren-How Pen, et al.
Shock (Augusta, Ga.)|December 9, 2008
Cardioprotective effect of therapeutic hypothermia for postresuscitation myocardial dysfunctionChiung-Yuan Hsu, Chien-Hua Huang, Wei-Tien Chang, et al.
Rapid Communications in Mass Spectrometry : RCM|September 11, 2019
Determination of synthetic cathinone α-pyrrolidinovalero-phenone and its metabolite in urine using solid-phase extraction and gas chromatography-mass spectrometryKai-Wen Cheng, Chien-Ming Hsieh, Huei-Wen Chen, et al.
Scientific Reports|September 25, 2015
Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer ProgressionAng Yuan, Yi-Jing Hsiao, Hsuan-Yu Chen, et al.
Molecular Pharmacology|January 15, 2004
Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysisHuei-Wen Chen, Sung-Liang Yu, Jeremy J W Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment naïve advanced EGFR-mutant lung adenocarcinoma patientsKuo-Hsuan Hsu, Yen-Hsiang Huang, Jeng-Sen Tseng, et al.
Nano Letters|August 30, 2013
Focal amplification of HOXD-harboring chromosome region is implicated in multiple-walled carbon nanotubes-induced carcinogenicityPing Wu, Shin-Sheng Yuan, Chao-Chi Ho, et al.
Cancer Research and Treatment|January 16, 2018
The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung AdenocarcinomaYen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng-Sen Tseng, et al.
Pageof 22